These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23172799)

  • 1. Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
    Mashhood A; Railkar R; Yokoo T; Levin Y; Clark L; Fox-Bosetti S; Middleton MS; Riek J; Kauh E; Dardzinski BJ; Williams D; Sirlin C; Shire NJ
    J Magn Reson Imaging; 2013 Jun; 37(6):1359-70. PubMed ID: 23172799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fat quantification by dual-echo MR imaging outperforms traditional histopathological analysis.
    Fischer MA; Raptis DA; Montani M; Graf R; Clavien PA; Nanz D; Alkadhi H; Scheffel H
    Acad Radiol; 2012 Oct; 19(10):1208-14. PubMed ID: 22841289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 3D two-point Dixon and standard 2D dual-echo breath-hold sequences for detection and quantification of fat content in renal angiomyolipoma.
    Rosenkrantz AB; Raj S; Babb JS; Chandarana H
    Eur J Radiol; 2012 Jan; 81(1):47-51. PubMed ID: 21126839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI.
    Joe E; Lee JM; Kim KW; Lee KB; Kim SJ; Baek JH; Shin CI; Suh KS; Yi NJ; Han JK; Choi BI
    J Magn Reson Imaging; 2012 Nov; 36(5):1124-30. PubMed ID: 22761083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
    Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
    Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.
    Deng J; Fishbein MH; Rigsby CK; Zhang G; Schoeneman SE; Donaldson JS
    Pediatr Radiol; 2014 Nov; 44(11):1379-87. PubMed ID: 24840769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver: segment-specific analysis of B1 field homogeneity at 3.0-T MR imaging with single-source versus dual-source parallel radiofrequency excitation.
    Pazahr S; Fischer MA; Chuck N; Luechinger R; Schick F; Nanz D; Boss A
    Radiology; 2012 Nov; 265(2):591-9. PubMed ID: 22929333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients.
    Leitão HS; Paulino C; Rodrigues D; Gonçalves SI; Marques C; Carvalheiro M; Geraldes CF; Caseiro-Alves F
    Acad Radiol; 2013 Aug; 20(8):957-61. PubMed ID: 23830602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
    Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
    J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR Quantification of the Fatty Fraction from T2*-corrected Dixon Fat/Water Separation Volume-interpolated Breathhold Examination (VIBE) in the Assessment of Muscle Atrophy in Rotator Cuff Tears.
    Lee YH; Kim S; Lim D; Song HT; Suh JS
    Acad Radiol; 2015 Jul; 22(7):909-17. PubMed ID: 24709378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
    Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of liver fat in the presence of iron with MRI using T2* correction: a clinical approach.
    Henninger B; Kremser C; Rauch S; Eder R; Judmaier W; Zoller H; Michaely H; Schocke M
    Eur Radiol; 2013 Jun; 23(6):1643-9. PubMed ID: 23334458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the artifacts caused by metallic implants in breast MRI using dual-echo dixon versus conventional fat-suppression techniques.
    Le Y; Kipfer HD; Majidi SS; Holz S; Lin C
    AJR Am J Roentgenol; 2014 Sep; 203(3):W307-14. PubMed ID: 25148189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a phantom to compare MR techniques for determining the ratio of intraabdominal to subcutaneous adipose tissue.
    Donnelly LF; O'Brien KJ; Dardzinski BJ; Poe SA; Bean JA; Holland SK; Daniels SR
    AJR Am J Roentgenol; 2003 Apr; 180(4):993-8. PubMed ID: 12646443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.